ATRA inhibits the proliferation of DU145 prostate cancer cells through reducing the methylation level of HOXB13 gene.
All-trans retinoic acid (ATRA) has been widely investigated for treatments of many cancers including prostate cancer. HOXB13, silenced in androgen receptor-negative (AR(-)) prostate cancer cells, plays a role in AR(-) prostate cancer cell growth arrest. In this study we intended to elucidate the mec...
Main Authors: | Zhiwei Liu, Guoling Ren, Chenyan Shangguan, Lijing Guo, Zhixiong Dong, Yueyang Li, Weina Zhang, Li Zhao, Pingfu Hou, Yu Zhang, Xiuli Wang, Jun Lu, Baiqu Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3396626?pdf=render |
Similar Items
-
The Role of HOXB13 in Prostate Cancer
by: Marta Ribeiro José Cardoso
Published: (2019) -
HOXB13 mutations and prostate cancer in Poland
by: Kluźniak Wojciech, et al.
Published: (2012-12-01) -
Prostate cancer risk variants of the HOXB genetic locus
by: William D. Dupont, et al.
Published: (2021-05-01) -
Long noncoding RNA HOXB13‐AS1 regulates HOXB13 gene methylation by interacting with EZH2 in glioma
by: Yu Xiong, et al.
Published: (2018-09-01) -
HOXB13 and other high penetrant genes for prostate cancer
by: Patrick G Pilie, et al.
Published: (2016-01-01)